SCHEMBL20182371

SCHEMBL20182371

CCCC(F)(F)Oc1ccc(-c2ccc(-c3c4nsnc4c(-c4ccc(-c5ccc(OC(C)(F)F)cc5)s4)c4nc(C)c(C)nc34)s2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18217193 0.96 APP (0.32) —
SCHEMBL18217178 0.87 APP (0.31) —
SCHEMBL21134088 0.84 APP (0.33) —
SCHEMBL21241758 0.82 APP (0.33) —
SCHEMBL19799086 0.81 APP (0.32) —
SCHEMBL16265228 0.80 APP (0.36) —
SCHEMBL22022374 0.77 APP (0.39) —
SCHEMBL21774728 0.76 APP (0.36) —
SCHEMBL16546541 0.75 APP (0.36) —
SCHEMBL16546543 0.75 APP (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738240-B2 Thiadiazoloquinoxaline derivatives MERCK PATENT GMBH (DE) 2020-08-11 — — US disclosed
US-20180142153-A1 THIADIAZOLOQUINOXALINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-05-24 — — US disclosed
Send feedback